Otilimab
Top View
- Interim Clinical Guidance for Adults with Suspected Or Confirmed Covid-19 in Belgium
- Nucleic Acid-Based Approaches for Tumor Therapy
- PDF of Antibody News
- The Society for Immunotherapy of Cancer Perspective on Regulation of Interleukin-6 Signaling in COVID-19- Related Systemic Inflammatory Response
- Managing the Covid-19 Pandemic: Therapeutics Are As Important As Vaccines
- GM-CSF: a Promising Target in Inflammation and Autoimmunity
- Journal for Immunotherapy of Cancer (JITC) Preprint
- 1 Pathophysiology of Acute Respiratory Syndrome
- Gilead to File Filgotinib for RA in 2019, Earlier Than Forecast
- University of Birmingham Efficacy, Patient-Reported Outcomes, And
- Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
- Q2 2020 Results Slides
- Rxoutlook® 3Rd Quarter 2021
- GM-CSF-Based Treatments in COVID-19: Reconciling Opposing Therapeutic Approaches
- Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
- Winter 2021 Pharmacy Market Outlook 2 Table of Contents
- The Role of GM-CSF Posted July 30, 2020
- New Breakthrough in the Treatment of Rheumatoid Arthritis 25 November 2020